WAVwatch 2.0 wearable sound device to help reduce everyday stress
Sound Stops Stress Study: Evaluating the WAVwatch Effect
This remote study will test whether wearing the WAVwatch 2.0 sound-frequency device can reduce stress and everyday anxiety for English-speaking adults living in the U.S.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Efforia, Inc Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT07281989 on ClinicalTrials.gov |
What this trial studies
This decentralized, remotely administered trial asks participants to use the WAVwatch 2.0, a wearable that delivers targeted sound frequencies, and report changes in stress and anxiety. Participants will be screened for basic eligibility (U.S. resident, English literacy) and exclusions such as skin sensitivities, auditory conditions, pregnancy, or severe mental health disorders. Outcomes will focus on self-reported stress and anxiety measures and overall life satisfaction, with participants receiving personalized feedback on their results. The trial aims to provide data-driven information about whether the device produces measurable short-term changes in well-being.
Who should consider this trial
Good fit: Ideal candidates are English-literate adults in the U.S. without skin or auditory sensitivities, who are not pregnant and do not have severe anxiety or other serious mental health disorders.
Not a fit: People with skin or ear sensitivities, auditory conditions, pregnancy, severe anxiety or other major mental health disorders, or those who become easily irritated by the device are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, the device could offer a non-drug, wearable option for people seeking to reduce everyday stress and improve wellbeing.
How similar studies have performed: Sound-based and frequency therapies have some small, mixed studies suggesting possible benefits but robust, large-scale randomized evidence is limited, so this approach remains relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with skin sensitivities * Individuals with auditory conditions * Individuals with severe anxiety or mental health disorders * Pregnancy * Individuals prone to irritation or frustration
Where this trial is running
New York, New York
- Efforia — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Matthew Amsden
- Email: help@efforia.com
- Phone: 646-679-2479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.